These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 27665778)
1. Transcriptome analyses demonstrate that Peroxisome Proliferator-Activated Receptor α (PPARα) activity of an ultraviolet absorber, 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole, as possible mechanism of their toxicity and the gender differences. Hirata-Koizumi M; Ise R; Kato H; Matsuyama T; Nishimaki-Mogami T; Takahashi M; Ono A; Ema M; Hirose A J Toxicol Sci; 2016; 41(5):693-700. PubMed ID: 27665778 [TBL] [Abstract][Full Text] [Related]
2. Disappearance of gender-related difference in the toxicity of benzotriazole ultraviolet absorber in juvenile rats. Hirata-Koizumi M; Matsuyama T; Imai T; Hirose A; Kamata E; Ema M Congenit Anom (Kyoto); 2009 Dec; 49(4):247-52. PubMed ID: 20021483 [TBL] [Abstract][Full Text] [Related]
3. Gender-related difference in the toxicity of 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in rats: relationship to the plasma concentration, in vitro hepatic metabolism, and effects on hepatic metabolizing enzyme activity. Hirata-Koizumi M; Matsuno K; Kawabata M; Yajima K; Matsuyama T; Hirose A; Kamata E; Ema M Drug Chem Toxicol; 2009; 32(3):204-14. PubMed ID: 19538016 [TBL] [Abstract][Full Text] [Related]
4. Lack of gender-related difference in the toxicity of 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in preweaning rats. Hirata-Koizumi M; Matsuyama T; Imai T; Hirose A; Kamata E; Ema M Drug Chem Toxicol; 2008; 31(2):275-87. PubMed ID: 18330788 [TBL] [Abstract][Full Text] [Related]
5. Gonadal influence on the toxicity of 2-(2'-hydroxy-3',5'-di-tert-butylphenyl) benzotriazole in rats. Hirata-Koizumi M; Matsuyama T; Imai T; Hirose A; Kamata E; Ema M Drug Chem Toxicol; 2008; 31(1):115-26. PubMed ID: 18161511 [TBL] [Abstract][Full Text] [Related]
6. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling. Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994 [TBL] [Abstract][Full Text] [Related]
7. A 52-week repeated dose toxicity study of ultraviolet absorber 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole in rats. Hirata-Koizumi M; Ogata H; Imai T; Hirose A; Kamata E; Ema M Drug Chem Toxicol; 2008; 31(1):81-96. PubMed ID: 18161509 [TBL] [Abstract][Full Text] [Related]
8. Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators. Tamura K; Ono A; Miyagishima T; Nagao T; Urushidani T J Toxicol Sci; 2006 Dec; 31(5):471-90. PubMed ID: 17202761 [TBL] [Abstract][Full Text] [Related]
9. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha. Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962 [TBL] [Abstract][Full Text] [Related]
10. A 28-day repeated dose toxicity study of ultraviolet absorber 2-(2'-hydroxy-3',5'-di-tert-butylphenyl) benzotriazole in rats. Hirata-Koizumi M; Watari N; Mukai D; Imai T; Hirose A; Kamata E; Ema M Drug Chem Toxicol; 2007; 30(4):327-41. PubMed ID: 17934922 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor α agonist-induced histidine decarboxylase gene expression in the rat and mouse liver. Amagase Y; Mizukawa Y; Urushidani T J Toxicol Sci; 2020; 45(8):475-492. PubMed ID: 32741898 [TBL] [Abstract][Full Text] [Related]
12. Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway. Zhang Y; Guo H; Hassan HM; Ding PP; Su Y; Song Y; Wang T; Sun L; Zhang L; Jiang Z J Appl Toxicol; 2016 Dec; 36(12):1579-1590. PubMed ID: 27071702 [TBL] [Abstract][Full Text] [Related]
14. Toxicogenomic analysis of the gene expression changes in rat liver after a 28-day oral Tripterygium wilfordii multiglycoside exposure. Zhang Y; Jiang Z; Xue M; Zhang S; Wang Y; Zhang L J Ethnopharmacol; 2012 May; 141(1):170-7. PubMed ID: 22366672 [TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524 [TBL] [Abstract][Full Text] [Related]
16. Extraction of peroxisome proliferator-activated receptor α agonist-induced lipid metabolism-related and unrelated genes in rat liver and analysis of their genomic location. Mizukawa Y; Amagase Y; Urushidani T J Toxicol Sci; 2020; 45(8):449-473. PubMed ID: 32741897 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats. Chen X; Li M; Sun W; Bi Y; Cai M; Liang H; Yu Q; He X; Weng J Biochem Biophys Res Commun; 2008 Apr; 368(4):865-70. PubMed ID: 18267115 [TBL] [Abstract][Full Text] [Related]
18. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Gonzalez FJ; Shah YM Toxicology; 2008 Apr; 246(1):2-8. PubMed ID: 18006136 [TBL] [Abstract][Full Text] [Related]
19. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats. Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504 [TBL] [Abstract][Full Text] [Related]
20. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4. Sanguino E; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]